20 items found

Tags: Pharmacology risk reduction

Filter Results
  • dataset

    Observed outcomes by treatment arm and by the ACCORD-BP trial population’s pr...

    Observed outcomes by treatment arm and by the ACCORD-BP trial population’s predicted benefit/harm (validation cohort).
  • dataset

    Observed outcomes by treatment arm and by benefit/harm subgroup for the SPRIN...

    Observed outcomes by treatment arm and by benefit/harm subgroup for the SPRINT trial (derivation cohort) and ACCORD-BP trial (validation cohort) when applying models fit by...
  • dataset

    r37980778c78--0a931cd03bcbddcb42553a3fd7018d87

    Baseline characteristics of the SPRINT trial participants included for model derivation (N = 9,069) and ACCORD-BP trial participants included for model validation (N = 4,498).
  • dataset

    Baseline characteristics of participants.

    Data are presented as mean±SD, median (interquartile range) or percent. Chi-square test for categorical variables, the unpaired t test or Mann-Whitney U test for continuous...
  • dataset

    Rural and Urban poverty ratio for India calculated with aggregate and micro d...

    Rural and Urban poverty ratio for India calculated with aggregate and micro data and the difference between the two, before and after medicine purchase.
  • dataset

    r37980778c78--ca1926f2b4ce9d6fd5951575f6169687

    Proportional hazard regression analysis of cardiovascular mortality in the study population with a basal selenium level < 65 μg/L (mean value) during an intervention time of...
  • dataset

    dedup_wf_001--8c850ab7ba1b764088d86e69b0bbbed7

    Survival data collected in the experimental fields of FORBIO (http://www.treedivbelgium.ugent.be/). This includes data at the plot level for the sites Hechtel-Eksel, Zedelgem...
  • dataset

    r37980778c78--4d99f1ab43861f80bf04e2ea9137adfc

    Comparison of discrimination and calibration for models fit by elastic net regularization versus traditional backwards selection.
  • dataset

    r37980778c78--56905ae4677c893a88bec378abb0acf0

    Risk score for harm from intensive blood pressure treatment, developed from the SPRINT trial.
  • dataset

    Blue-Action project factsheet (Nov. 2017)

    Project factsheet updated for the workshop #Climate services at work, Projects exchange and networking lab", held in Brussels, 29 -30 November 2017 - CDMA building. Organiser:...
  • dataset

    r37980778c78--8ff1da1f0b0aaee0528980600e5ff5cf

    Risk score for benefit from intensive blood pressure treatment, developed from the SPRINT trial.
  • dataset

    Poverty ratio and poverty gap index for rural and urban India before and afte...

    Poverty ratio and poverty gap index for rural and urban India before and after medication purchase, calculated by using aggregate data.
  • dataset

    r37980778c78--22b45d53a2c4e79d33ef1a3288d469d8

    Cost-effectiveness of cardiovascular medicines for primary prevention of Ischemic Heart Disease.
  • dataset

    Estimates of the number of people that could benefit from cardiovascular medi...

    Estimates of the number of people that could benefit from cardiovascular medicines and the resulting number of people financially burdened or impoverished due to medication...
  • dataset

    Baseline patient characteristics.

    Data are presented as median (interquartile range) or number (n [%]), as appropriate. Baseline characteristics were compared between the two diagnostic groups using a...
  • dataset

    r37980778c78--ceca5efea0530ad16926908b9116ca30

    Common drugs for cardiovascular disease prevention in the national essential medicines list and their prices.
  • dataset

    r37980778c78--aebdd7ae91903c50254e3dbeffed0334

    Observed outcomes by treatment arm and by the SPRINT trial population’s predicted benefit/harm (derivation cohort).
  • dataset

    r37980778c78--30d090c64503da4540a0493d6ed51a35

    BackgroundIntensive blood pressure (BP) treatment can avert cardiovascular disease (CVD) events but can cause some serious adverse events. We sought to develop and validate risk...
  • dataset

    r37980778c78--7e08c43f7b4af50ca8dd2c0a3006b379

    Proportional hazard regression analysis of cardiovascular mortality in the study population with a basal selenium level of 65–85 μg/L (mean value) during an intervention time of...
  • dataset

    Baseline characteristics of the study population divided into a serum seleniu...

    Baseline characteristics of the study population divided into a serum selenium concentration of 85 μg/L.